[Medulloblastoma: towards new prognostic factors].

Article

[Medulloblastoma: towards new prognostic factors].

Neuro-Chirurgie - 1 Jan 1991

San-Galli F, Maire J P, Guérin J

Abstract excerpt

Current therapeutic protocols for medulloblastoma combining, with surgery, radiation therapy and chemotherapy allow 5-year survival rates of over 50%. However these therapies induce mainly in children long-term adverse effects, which produce a therapeutic dilemma emphasizing the need for reliable prognostic factors in order to adapt the treatment modalities to the degree of the tumor's aggressiveness....

Topics

Antibodies, Monoclonal
Bromodeoxyuridine
Cerebellar Neoplasms
Chromosome Aberrations
Chromosome Disorders
DNA, Neoplasm
Flow Cytometry
Humans
Medulloblastoma
Neoplasm Invasiveness
Neurobiology
Phenotype

Prognosis

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

[Medulloblastoma: towards new prognostic factors].PMID 2017290Read

[Evolution of the management of pediatric and adult medulloblastoma].Semantic proximity Read

Stratification of medulloblastoma on the basis of histopathological grading.Semantic proximity Read

[What is new in pediatric oncology?].Semantic proximity Read

Hepatoblastoma: DNA nuclear content, proliferative indices, and pathologySemantic proximity Read

Medulloblastoma: Tumor Biology and Relevance to Treatment and Prognosis ParadigmSemantic proximity Read

Medulloblastoma: what is the role of molecular genetics?Semantic proximity Read

[Cytogenetic diagnosis of brain tumors].Semantic proximity Read

Medulloblastoma in the age of molecular subgroups: a reviewSemantic proximity Read